Novozymes A/S (FRA:NZM2)

Market Cap	23.34B -14.3%
Revenue (ttm)	4.20B +3.5%
Net Income	596.70M +30.1%
EPS	1.28 -19.1%
Shares Out	n/a
PE Ratio	39.12
Forward PE	22.85
Dividend	0.87 (1.74%)
Ex-Dividend Date	Mar 24, 2026

Volume	n/a
Open	50.28
Previous Close	50.80
Day's Range	49.48 - 50.28
52-Week Range	44.99 - 65.38
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 5, 2026

About Novozymes

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; e...

• Industry: Miscellaneous Chemical Products
• Founded: 1925
• Employees: 11,098
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: NZM2

Financial Performance

In 2025, Novozymes's revenue was 4.16 billion, an increase of 8.45% compared to the previous year's 3.83 billion. Earnings were 583.60 million, an increase of 90.84%.